Cerebral microdialysis (CMD)

View Details
logo
Parent item
  • Microdialysis is a technique for sampling the brain extracellular space. An invasive probe is inserted into the brain substance and perfused with fluid (perfusate) at ultralow flow rates (typically 0.3 μl/minute). A semipermeable membrane at the tip of the catheter allows substances to diffuse into the catheter and are recovered in the exiting fluid (microdialysate).
  • For clinical purposes, the commonest analytes are glucose, lactate, pyruvate, glutamate (an excitotoxic neurotransmitter) and glycerol (a measure of cellular membrane breakdown).
  • The ratio between lactate and pyruvate (LPR, lactate-pyruvate ratio) provides a measure of the balance between anaerobic and aerobic respiration.
  • An LPR more than 25 is regarded as pathological and correlates with poor clinical outcome in TBI.
Microdialysis probe
Microdialysis probe
  • Allows bedside analysis of biochemical substances in brain tissue extracellular fluid.
  • Location of catheter
    • Placed in ‘at risk’ tissue so that biochemical changes in the area of brain most vulnerable to secondary insults can be monitored.
  • It may identify cerebral compromise at the cellular level before it is detectable clinically or by other monitored variables.
  • Compounds assayed include:
    • Lactate/pyruvate ratio
      • A marker of anaerobic metabolism
        • >25 marker of poor clinical outcome
          • Elevated lactate:pyruvate ratio (LPR) more than 40 combined with low brain glucose (<0.7– 1 mmol/ litre) suggests severe hypoxia/ischaemia and correlates with poor outcome after TBI (Timofeev et al., 2011).
        • Marker of anaerobic and aerobic respiration
      • Correlates with outcome after TBI.
      • Increase in the lactate/pyruvate ratio can be due to
        • Cerebral ischaemia or
        • Mitochondrial dysfunction.
          • In patients with elevated cerebral lactate/ pyruvate ratio (LPR), microdialysis demonstrates that exogenous lactate therapy significantly increases cerebral glucose levels.
          • This correlates with previous evidence that lactate is directly oxidized to pyruvate in the mitochondria of neurons and astrocyte to contribute to cerebral aerobic metabolism (Lazaridis and Andrews, 2014).
      • Is a good indicator of widespread mitochondrial dysfunction causing metabolic depression following TBI,
        • Further impairing brain capacity to meet metabolic demands in coping with secondary insults.
      • Low CMRO2 indicates irreversible cell injury,
      • LPR a sensitive marker of reversible mitochondrial dysfunction in regions with no observable tissue damage.
    • Glucose
    • Glutamate
    • Urea and electrolytes
      • K+
      • Calcium.
  • Some observational data:
    • Lactate levels increase during episodes of SjVO2 desaturation
    • Decreased extracellular glucose was associated with increased mortality